News

New Trump vaccine policy might limit access to your future COVID shots: 10 points
The US Food and Drug Administration changes Covid-19 vaccine approval process. Access to seasonal boosters is restricted for ...
Novavax: Nuvaxovid FDA Approval Unlocks Several Bullish Stimuli
Novavax's full FDA approval for NUVAXOVID is a transformative milestone, unlocking a $175M Sanofi payment and validating ...
Managed Healthcare Executive1h
Concerns Grow Over Potential Delays in FDA Drug Approvals Amid Government Cuts
In this final interview of a three-part video series, Jeffrey Casberg, M.S., vice president of clinical pharmacy at IPD ...
BioSpace3h
Pfizer’s $6B China Deal, Drug Pricing and FDA’s New COVID Vaccine Plan
China continues to be a source of innovation as Pfizer strikes biggest pact yet; HHS provides more info on Trump’s Most Favored Nation executive order; FDA Commissioner Marty Makary and CBER director ...
The Daily News7h
Vaccine policy limits access to COVID shots
The Trump administration said Tuesday it will limit approval for seasonal COVID-19 shots to seniors and others at high risk ...
McKnight's Long-Term Care News10h
Older adults gain new COVID vaccine option as FDA approves protein-based shot
The US Food and Drug Administration has fully approved a new COVID vaccine option specifically targeting high-risk individuals, including seniors. The protein-based Nuvaxovid vaccine, produced by ...
FDA tightens requirements for COVID vaccine, adding trials for healthy adults
The U.S. Food and Drug Administration on Tuesday said it plans to require new clinical trials for approval of annual COVID-19 ...
The FDA is making it more difficult for Americans to get vaccinated for covid
In the NEJM article, the FDA notes that covid booster uptake has been low in the US, with less than a quarter of people ...
Report: U.S. young men feel lonelier than other age groups
About a fourth of younger men surveyed in the United States feel lonely, which is significantly higher than the national ...